4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Sudden cardiac death (SCD) from cardiac arrest is a major international public health
problem accounting for an estimated 15%–20% of all deaths. Although resuscitation rates …

Despite major therapeutic advances over the last decades, complex supraventricular and
ventricular arrhythmias (VAs), particularly in the emergency setting or during …

Zaman and Kovoor Primary Prevention of SCD Early After MI 2427 in Acute Myocardial
Infarction Trial (DINAMIT) investigators implanted defibrillators 6 to 40 days after MI in …

Background Myocardial fibrosis (MF) forms part of the arrhythmic substrate for ventricular
arrhythmias (VAs). Objectives This study sought to determine whether total myocardial …

Sudden cardiac death (SCD) accounts for∼ 50% of mortality after myocardial infarction (MI).
Most SCDs result from ventricular tachyarrhythmias, and the tachycardias that precipitate …

Therapies that target scar formation after myocardial infarction (MI) could prevent ensuing
heart failure or death from ventricular arrhythmias. We have previously shown that …

Sudden Cardiac Death (SCD) is a major public health issue, accounting for half of all
cardiovascular deaths world-wide. The implantable cardioverter-defibrillator (ICD) has been …